Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

Ikena Oncology (IKNA)

Ikena Oncology Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:IKNA
DateTimeSourceHeadlineSymbolCompany
10/06/202421:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:IKNAIkena Oncology Inc
28/05/202421:42GlobeNewswire Inc.UPDATE – Ikena Oncology Announces Strategic UpdateNASDAQ:IKNAIkena Oncology Inc
28/05/202421:24Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:IKNAIkena Oncology Inc
28/05/202421:15GlobeNewswire Inc.Ikena Oncology Announces Strategic UpdateNASDAQ:IKNAIkena Oncology Inc
13/05/202421:45GlobeNewswire Inc.Ikena Oncology Reports First Quarter 2024 Financial Results and Corporate UpdateNASDAQ:IKNAIkena Oncology Inc
13/05/202421:33Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:IKNAIkena Oncology Inc
10/04/202413:00GlobeNewswire Inc.Ikena Oncology to Present at the Stifel 2024 Virtual Targeted Oncology ForumNASDAQ:IKNAIkena Oncology Inc
12/03/202412:00GlobeNewswire Inc.Ikena Oncology Reports Fourth Quarter and Full Year 2023 Financial ResultsNASDAQ:IKNAIkena Oncology Inc
05/03/202421:05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IKNAIkena Oncology Inc
05/03/202421:01Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:IKNAIkena Oncology Inc
27/02/202413:00GlobeNewswire Inc.Ikena Oncology to Participate in TD Cowen 44th Annual Health Care ConferenceNASDAQ:IKNAIkena Oncology Inc
21/02/202421:29Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:IKNAIkena Oncology Inc
21/02/202421:15GlobeNewswire Inc.Ikena Oncology Appoints Caroline Germa, M.D. as Chief Medical OfficerNASDAQ:IKNAIkena Oncology Inc
02/02/202422:15Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IKNAIkena Oncology Inc
02/02/202422:07Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IKNAIkena Oncology Inc
18/01/202421:26Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:IKNAIkena Oncology Inc
18/01/202421:05GlobeNewswire Inc.Ikena Oncology Outlines Key Priorities and Provides Corporate UpdatesNASDAQ:IKNAIkena Oncology Inc
09/11/202312:30Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:IKNAIkena Oncology Inc
09/11/202312:09Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:IKNAIkena Oncology Inc
09/11/202312:00GlobeNewswire Inc.Ikena Oncology Shares Initial Positive and Differentiated Dose Escalation Data from IK-930 Phase I Trial and Reports Third Quarter 2023 Financial ResultsNASDAQ:IKNAIkena Oncology Inc
07/11/202313:00GlobeNewswire Inc.Ikena Oncology to Present at Multiple November 2023 Investor ConferencesNASDAQ:IKNAIkena Oncology Inc
11/10/202322:10Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:IKNAIkena Oncology Inc
25/09/202321:05Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:IKNAIkena Oncology Inc
15/09/202321:05Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:IKNAIkena Oncology Inc
12/09/202321:11Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:IKNAIkena Oncology Inc
11/09/202305:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:IKNAIkena Oncology Inc
05/09/202313:00GlobeNewswire Inc.Ikena Oncology to Participate in September 2023 Investor ConferencesNASDAQ:IKNAIkena Oncology Inc
18/08/202321:03Edgar (US Regulatory)Form D - Notice of Exempt Offering of SecuritiesNASDAQ:IKNAIkena Oncology Inc
18/08/202321:02Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:IKNAIkena Oncology Inc
10/08/202313:00GlobeNewswire Inc.Ikena Oncology Reports Second Quarter 2023 Financial Results and Corporate UpdateNASDAQ:IKNAIkena Oncology Inc
 Showing the most relevant articles for your search:NASDAQ:IKNA